Thurston, Springer, Miller, Herd & Titak, Inc. Embecta Corp. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $283 Million
- Q2 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 138 shares of EMBC stock, worth $2,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138Holding current value
$2,112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EMBC
# of Institutions
397Shares Held
52.9MCall Options Held
215KPut Options Held
83.3K-
Black Rock Inc. New York, NY9.19MShares$141 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.29MShares$112 Million0.0% of portfolio
-
River Road Asset Management, LLC3.58MShares$54.9 Million0.66% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.44MShares$52.7 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO3.16MShares$48.4 Million0.02% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $885M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...